Cambridge University Hospitals NHS Foundation Trust Clinical Trials
Sponsors / Cambridge University Hospitals NHS Foundation Trust
Cambridge University Hospitals NHS Foundation Trust is listed as the lead sponsor on 221 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 28 are in recruitment, 12 are active non-recruiting, and 96 have reached completion. 13 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Across the portfolio, planned enrollment totals 216,341 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
221
Total Trials
28
Recruiting
12
Other Active
96
Completed
13
Terminated / Withdrawn
216,341
Total Enrollment
Termination reasons: Other54% · Recruitment38% · Funding8%
Recent Terminations
- Cogan Syndrome"NIHR withdrawal of funding"
- NCT03038750 Stopped Jun 2023Cardiovascular Diseases"The delay due to suspending the study due to covid, subsequent problems in synthesis, supply and yield of BQ123, prevented completion of the study as planned."
- Allograft"DMC noted that the primary end point of healed index ulcer at 12 weeks was reached only in 11.5%, whereas a higher figure of 42.5% had been used for the original power calculation, suggesting the trial is significantly underpowered."
- Antibody-mediated Rejection"Stopped at start of COVID-19 pandemic - non-feasible"
- NCT03043898 Stopped Apr 2020Asthma"COVID-19"
- Pancreas Cancer"terminated due to slow accrual"
- Dumping Syndrome"Reached scientific goals, further recruitment would not further advance the findings of study."
- Multiple Sclerosis"interim anlaysis failed: palifermin does not promote thymopoeisis after alemtuzumab"
- Arthritis, Rheumatoid"A decision to stop the study was made by the site and GSK project team based on pre-defined stopping criteria in the protocol"
- Prostate Cancer"Problems with recruitment"
Active Trials (12 total)
- NCT03049254
- NCT07538440
- Parkinson Disease PHASE2NCT07157735
- Glioblastoma Multiforme (GBM) PHASE1/PHASE2NCT07391215
- Hypertension NANCT07364175
- Diffuse Hemispheric Glioma, H3 G34-Mutant PHASE1/PHASE2NCT06630260
- NCT07341230
- NCT06584123
- Parkinson Disease PHASE1NCT05635409
- Obesity NANCT05866406
- NCT04931498
- NCT05717647
- NCT07201038
- Pancreatic Cancer PHASE2NCT05093231
- NCT07026656
- Prostate Cancer PHASE2NCT05191680
- NCT05975554
- NCT03305250
- NCT06959719
- NCT06632236